GB201112607D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB201112607D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2011-07-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1112607.5A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-07-22

Filing date

2011-07-22

Publication date

2011-09-07

2011-07-22 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2011-07-22 Priority to GBGB1112607.5A priority Critical patent/GB201112607D0/en

2011-09-07 Publication of GB201112607D0 publication Critical patent/GB201112607D0/en

2011-10-17 Priority to PCT/EP2011/068085 priority patent/WO2012052390A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB1112607.5A 2010-10-19 2011-07-22 Novel compounds Ceased GB201112607D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1112607.5A GB201112607D0 (en)	2011-07-22	2011-07-22	Novel compounds
PCT/EP2011/068085 WO2012052390A1 (en)	2010-10-19	2011-10-17	N-2-(2-pyridinyl)-4-pyrimidinyl-beta-alanine derivatives as inhibitors of histone demethylase jmjd3

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1112607.5A GB201112607D0 (en)	2011-07-22	2011-07-22	Novel compounds

Publications (1)

Publication Number	Publication Date
GB201112607D0 true GB201112607D0 (en)	2011-09-07

Family

ID=44652147

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1112607.5A Ceased GB201112607D0 (en)	2010-10-19	2011-07-22	Novel compounds

Country Status (2)

Country	Link
GB (1)	GB201112607D0 (en)
WO (1)	WO2012052390A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5941546B2 (en)	2011-09-02	2016-06-29	パーデュー、ファーマ、リミテッド、パートナーシップ	Pyrimidines as sodium channel blockers
PE20151417A1 (en) *	2012-12-21	2015-10-10	Quanticel Pharmaceuticals Inc	HISTONE DESMETILASE INHIBITORS
CN103524535B (en) *	2013-10-16	2016-07-13	苏州云轩医药科技有限公司	There is the Amido thiazole-pyridine heterocycle compound of activity of hedgehog path antagonist
CN103588771B (en) *	2013-01-15	2016-01-27	苏州云轩医药科技有限公司	There is the miazines antineoplastic compound of activity of hedgehog path antagonist
SI2961736T1 (en) *	2013-02-27	2018-06-29	Gilead Sciences, Inc.	Inhibitors of histone demethylases
US9133166B2 (en)	2013-03-14	2015-09-15	Quanticel Pharmaceuticals, Inc.	Histone demethylase inhibitors
SI2970211T1 (en) *	2013-03-15	2017-12-29	Quanticel Pharmaceuticals Inc.	Histone demethylase inhibitors
WO2014190035A2 (en) *	2013-05-21	2014-11-27	Dana-Farber Cancer Institute, Inc.	Compositions and methods for identification, assessment, prevention, and treatment of cancer using histone h3k27me2 biomarkers and modulators
JP6521535B2 (en)	2014-06-25	2019-05-29	セルジーンクオンティセルリサーチ，インク．	Histone demethylase inhibitors
US10206930B2 (en)	2015-08-14	2019-02-19	New York University	Methods for treating T-cell acute lymphoblastic leukemia
CN106608869B (en) *	2015-10-27	2020-08-04	中国科学院上海药物研究所	Histone demethylase JMJD3 inhibitor and preparation method and application thereof
CN106854181A (en) *	2015-12-08	2017-06-16	湖南华腾制药有限公司	A kind of preparation method of pyrimidine compound
CN120661674A (en)	2016-03-15	2025-09-19	奥莱松基因组股份有限公司	Combination of LSD1 inhibitors for the treatment of solid tumors
WO2018058034A1 (en)	2016-09-23	2018-03-29	Thomas Jefferson University	Drug-induced epigenetic remodeling to prevent fibrosis
MA51507A (en)	2016-12-09	2020-11-11	Constellation Pharmaceuticals Inc	MARKERS FOR PERSONALIZED CANCER TREATMENT WITH LSD1 INHIBITORS
CN106810538A (en) *	2017-01-09	2017-06-09	湖南华腾制药有限公司	A kind of preparation method of 2 pyrrole radicals pyrimidine derivatives
US20190374525A1 (en) *	2017-02-10	2019-12-12	Temple Otorongo Llc	Treatment of diabetes and associated metabolic conditions with epigenetic modulators
US11524011B2 (en) *	2017-09-01	2022-12-13	The Johns Hopkins University	H3K27 demethylase inhibitors in pediatric and juvenile osteoporosis
TWI815887B (en) *	2018-05-15	2023-09-21	美商愛彼特生物製藥股份有限公司	Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
CN113387938B (en) *	2020-03-11	2023-08-18	上海科技大学	A kind of substituted pyrimidine compound, its preparation method, intermediate and application
EP4281447A4 (en) *	2021-01-25	2025-06-04	Athos Therapeutics, Inc.	Triazine compounds and processes for their preparation and use
CN115466245B (en) *	2022-06-29	2024-04-16	深圳大学	A hydroxamic acid derivative of pyrimidine bipyridine and its preparation method and application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU570439B2 (en)	1983-03-28	1988-03-17	Compression Labs, Inc.	A combined intraframe and interframe transform coding system
US5681835A (en)	1994-04-25	1997-10-28	Glaxo Wellcome Inc.	Non-steroidal ligands for the estrogen receptor
GB9716557D0 (en)	1997-08-06	1997-10-08	Glaxo Group Ltd	Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
WO2009087224A1 (en)	2008-01-11	2009-07-16	Novartis Ag	Pyrimidines as kinase inhibitors
WO2009114011A1 (en)	2008-03-11	2009-09-17	President And Fellows Of Harvard College	Histone demethylation proteins and methods of use thereof
GB0818907D0 (en) *	2008-10-15	2008-11-19	Isis Innovation	Histone lysine demethylase inhibitors
LT2349324T (en)	2008-10-17	2017-12-27	Sanofi-Aventis Deutschland Gmbh	Combination of an insulin and a glp-1 agonist

2011
- 2011-07-22 GB GBGB1112607.5A patent/GB201112607D0/en not_active Ceased
- 2011-10-17 WO PCT/EP2011/068085 patent/WO2012052390A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2012052390A1 (en)	2012-04-26

Publication	Publication Date	Title
GB201114103D0 (en)	2011-09-28	Novel compounds
GB201106799D0 (en)	2011-06-01	Novel compounds
GB201107325D0 (en)	2011-06-15	Novel compounds
GB201116641D0 (en)	2011-11-09	Novel compounds
GB201106395D0 (en)	2011-06-01	Compounds
GB201109763D0 (en)	2011-07-27	Compounds
GB201112607D0 (en)	2011-09-07	Novel compounds
GB201107197D0 (en)	2011-06-15	Compounds
GB201111704D0 (en)	2011-08-24	Novel compounds
EP2717694A4 (en)	2014-11-12	Novel compounds
GB201122113D0 (en)	2012-02-01	Novel compounds
GB201110938D0 (en)	2011-08-10	Compounds
GB201105659D0 (en)	2011-05-18	Compounds
GB201118613D0 (en)	2011-12-07	Compounds
GB201109508D0 (en)	2011-07-20	Novel compounds
GB201113766D0 (en)	2011-09-21	Novel compounds
GB201111476D0 (en)	2011-08-17	Novel compounds
GB201111409D0 (en)	2011-08-17	Novel compounds
GB201111308D0 (en)	2011-08-17	Novel compounds
GB201111410D0 (en)	2011-08-17	Novel compounds
GB201111229D0 (en)	2011-08-17	Novel compounds
GB201109514D0 (en)	2011-07-20	Novel compounds
GB201104138D0 (en)	2011-04-27	Novel compounds
GB201103283D0 (en)	2011-04-13	Novel compounds
GB201115319D0 (en)	2011-10-19	Novel compounds

Legal Events

Date	Code	Title	Description
2013-01-16	AT	Applications terminated before publication under section 16(1)